首页 > 最新文献

Current Pharmacogenomics and Personalized Medicine最新文献

英文 中文
Tackling Cardiovascular Risk: New Evidence from Personalized Medicine 应对心血管风险:来自个性化医疗的新证据
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-06-23 DOI: 10.2174/1875692115666170508152128
R. Finelli, A. V. Pascale, P. Marotta, A. Guida, M. Ciccarelli
{"title":"Tackling Cardiovascular Risk: New Evidence from Personalized Medicine","authors":"R. Finelli, A. V. Pascale, P. Marotta, A. Guida, M. Ciccarelli","doi":"10.2174/1875692115666170508152128","DOIUrl":"https://doi.org/10.2174/1875692115666170508152128","url":null,"abstract":"","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72515703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender Differences in Response to Therapy for Cardiovascular Diseases 心血管疾病治疗反应的性别差异
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-05-31 DOI: 10.2174/1875692115666170508153322
Corbi Graziamaria, Ambrosino Immacolata, Komici Klara, Cellurale Michele, Lombardi Anna, F. Nicola
DOI: 10.2174/1875692115666170508153322 Abstract: In the last decades, aging of population is becoming even more prevalent, with consequent increasing requirement in health assistance and services. Physical and social environments can affect health directly, or through barriers or incentives conditioning opportunities, decisions and behavior. Moreover, the relationship with environment varies according to several personal characteristics including family background, sex and ethnicity. The impact of these factors is often skewed by these characteristics, leading to inequalities in health. In almost all countries, the older population is predominantly female. The prevalence and incidence of Cardiovascular Diseases (CVD) are reported to be lower in women than in men, increasing with age in both genders, but at advanced ages women outnumber men. Gender-differences in the contribution of various pathophysiological processes, combined with suboptimal recognition of female specificities, may explain sexdifferences in presentation and outcomes of CVD and also partially explain the differences in cardiovascular drug therapy related to gender, where other behavioral and cultural factors can be involved. Starting by the conflicting data in literature, the aim of this article is to summarize the gender differences available on the use of the main cardiovascular drugs, and the possible explanation for these disparities. Till date, data on gender differences in cardiovascular therapy are still controversial, and overall no established factors have been identified to discriminate the different approach in the choice of cardiovascular drugs by gender. Then further more structured and bigger trials should be performed to target these issues, and to better clarify the underlining involved mechanisms.
摘要:近几十年来,人口老龄化日益普遍,对卫生援助和服务的需求也随之增加。物质和社会环境可直接影响健康,或通过障碍或激励因素影响机会、决定和行为。此外,与环境的关系因家庭背景、性别和种族等个人特征而异。这些因素的影响往往受到这些特点的影响,导致健康方面的不平等。在几乎所有国家,老年人口主要是女性。据报道,心血管疾病(CVD)的流行率和发病率在女性中低于男性,随着年龄的增长而增加,但在老年妇女人数超过男性。各种病理生理过程中的性别差异,加上对女性特异性的不理想认识,可能解释了CVD的表现和结果的性别差异,也部分解释了与性别相关的心血管药物治疗的差异,其中其他行为和文化因素可能涉及。从文献中相互矛盾的数据开始,本文的目的是总结主要心血管药物使用的性别差异,以及这些差异的可能解释。迄今为止,关于心血管治疗中的性别差异的数据仍然存在争议,总体而言,没有确定的因素可以根据性别区分心血管药物选择的不同方法。然后应该进一步进行更有组织、规模更大的试验,以针对这些问题,并更好地阐明重点涉及的机制。
{"title":"Gender Differences in Response to Therapy for Cardiovascular Diseases","authors":"Corbi Graziamaria, Ambrosino Immacolata, Komici Klara, Cellurale Michele, Lombardi Anna, F. Nicola","doi":"10.2174/1875692115666170508153322","DOIUrl":"https://doi.org/10.2174/1875692115666170508153322","url":null,"abstract":"DOI: 10.2174/1875692115666170508153322 Abstract: In the last decades, aging of population is becoming even more prevalent, with consequent increasing requirement in health assistance and services. Physical and social environments can affect health directly, or through barriers or incentives conditioning opportunities, decisions and behavior. Moreover, the relationship with environment varies according to several personal characteristics including family background, sex and ethnicity. The impact of these factors is often skewed by these characteristics, leading to inequalities in health. In almost all countries, the older population is predominantly female. The prevalence and incidence of Cardiovascular Diseases (CVD) are reported to be lower in women than in men, increasing with age in both genders, but at advanced ages women outnumber men. Gender-differences in the contribution of various pathophysiological processes, combined with suboptimal recognition of female specificities, may explain sexdifferences in presentation and outcomes of CVD and also partially explain the differences in cardiovascular drug therapy related to gender, where other behavioral and cultural factors can be involved. Starting by the conflicting data in literature, the aim of this article is to summarize the gender differences available on the use of the main cardiovascular drugs, and the possible explanation for these disparities. Till date, data on gender differences in cardiovascular therapy are still controversial, and overall no established factors have been identified to discriminate the different approach in the choice of cardiovascular drugs by gender. Then further more structured and bigger trials should be performed to target these issues, and to better clarify the underlining involved mechanisms.","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"18 1","pages":"14-26"},"PeriodicalIF":0.0,"publicationDate":"2017-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75027763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Novel Drug Targets for the Treatment of Cardiac Diseases 治疗心脏疾病的新药物靶点
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-05-31 DOI: 10.2174/1875692115666170503105402
Marine Pingeon, B. Charlier, F. D. Lise, Francesca Mensitieri, F. Piaz, V. Izzo
{"title":"Novel Drug Targets for the Treatment of Cardiac Diseases","authors":"Marine Pingeon, B. Charlier, F. D. Lise, Francesca Mensitieri, F. Piaz, V. Izzo","doi":"10.2174/1875692115666170503105402","DOIUrl":"https://doi.org/10.2174/1875692115666170503105402","url":null,"abstract":"","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"106 1","pages":"32-44"},"PeriodicalIF":0.0,"publicationDate":"2017-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82539610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Impact of New Technologies on Pharmacogenomics 新技术对药物基因组学的影响
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-04-24 DOI: 10.2174/1875692115666170214152152
M. Isidoro-García, Almudena Sánchez-Martín, B. García‐Berrocal
{"title":"Impact of New Technologies on Pharmacogenomics","authors":"M. Isidoro-García, Almudena Sánchez-Martín, B. García‐Berrocal","doi":"10.2174/1875692115666170214152152","DOIUrl":"https://doi.org/10.2174/1875692115666170214152152","url":null,"abstract":"","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"31 1","pages":"74-85"},"PeriodicalIF":0.0,"publicationDate":"2017-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89922438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Editorial: CPPM Onward and Upward: Global Personalized Medicine Guided by Responsible Innovation 社论:CPPM向前和向上:以负责任的创新为指导的全球个性化医疗
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-04-24 DOI: 10.2174/187569211402170424205258
A. Llerena, V. Ozdemir
{"title":"Editorial: CPPM Onward and Upward: Global Personalized Medicine Guided by Responsible Innovation","authors":"A. Llerena, V. Ozdemir","doi":"10.2174/187569211402170424205258","DOIUrl":"https://doi.org/10.2174/187569211402170424205258","url":null,"abstract":"","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"1 1","pages":"66-67"},"PeriodicalIF":0.0,"publicationDate":"2017-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80889644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Developments of Differentiation Therapy of Acute Myeloid Leukemia 急性髓系白血病分化治疗的新进展
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-04-24 DOI: 10.2174/1875692115666170224094023
G. Castelli, E. Pelosi, U. Testa
{"title":"New Developments of Differentiation Therapy of Acute Myeloid Leukemia","authors":"G. Castelli, E. Pelosi, U. Testa","doi":"10.2174/1875692115666170224094023","DOIUrl":"https://doi.org/10.2174/1875692115666170224094023","url":null,"abstract":"","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"59 1","pages":"86-105"},"PeriodicalIF":0.0,"publicationDate":"2017-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89081844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DNA-drug Conjugates for Site-specific Delivery in Anti-cancer Therapy 抗癌治疗中靶向递送的dna -药物缀合物
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-04-24 DOI: 10.2174/1875692115666170208121925
K. Pramod
{"title":"DNA-drug Conjugates for Site-specific Delivery in Anti-cancer Therapy","authors":"K. Pramod","doi":"10.2174/1875692115666170208121925","DOIUrl":"https://doi.org/10.2174/1875692115666170208121925","url":null,"abstract":"","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"11 1","pages":"68-73"},"PeriodicalIF":0.0,"publicationDate":"2017-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76233166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs 个性化和循证医学的新见解- MicroRNAs的作用
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-04-24 DOI: 10.2174/1875692115666170403101207
Upinder Kaur, S. Chakrabarti, I. Gambhir
{"title":"Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs","authors":"Upinder Kaur, S. Chakrabarti, I. Gambhir","doi":"10.2174/1875692115666170403101207","DOIUrl":"https://doi.org/10.2174/1875692115666170403101207","url":null,"abstract":"","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"51 2 1","pages":"106-123"},"PeriodicalIF":0.0,"publicationDate":"2017-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87699046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exome Sequencing of Ovarian Cancer Patients to Identify Variants Predictive of Sensitivity to Platinum-based Chemotherapy 卵巢癌患者外显子组测序鉴定预测铂基化疗敏感性的变异
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-04-24 DOI: 10.2174/1875692115666170126152349
A. Semaan, K. Delfino, A. Wilber, Thomas K. Mathews, Kathy Robinson, L. Brard, S. Alanee
{"title":"Exome Sequencing of Ovarian Cancer Patients to Identify Variants Predictive of Sensitivity to Platinum-based Chemotherapy","authors":"A. Semaan, K. Delfino, A. Wilber, Thomas K. Mathews, Kathy Robinson, L. Brard, S. Alanee","doi":"10.2174/1875692115666170126152349","DOIUrl":"https://doi.org/10.2174/1875692115666170126152349","url":null,"abstract":"","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"73 1","pages":"124-133"},"PeriodicalIF":0.0,"publicationDate":"2017-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79488181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allele Frequencies of CYP2D6, CYP3A5 and DPYD Genes Polymorphisms in the Healthy Yakut Population 雅库特健康人群CYP2D6、CYP3A5和DPYD基因多态性的等位基因频率
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-01-16 DOI: 10.2174/1875692114666160801151257
F. F. Vasilyev, D. A. Danilova, V. Kaimonov, Y. Chertovskih, N. Maksimova
{"title":"Allele Frequencies of CYP2D6, CYP3A5 and DPYD Genes Polymorphisms in the Healthy Yakut Population","authors":"F. F. Vasilyev, D. A. Danilova, V. Kaimonov, Y. Chertovskih, N. Maksimova","doi":"10.2174/1875692114666160801151257","DOIUrl":"https://doi.org/10.2174/1875692114666160801151257","url":null,"abstract":"","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"25 1","pages":"50-55"},"PeriodicalIF":0.0,"publicationDate":"2017-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76649678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Pharmacogenomics and Personalized Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1